Letters: 10-year risk assessment tools may harm patients

Lately, I have been thinking more about the harm than good of various risk assessment tools.

Cardiovascular disease risk assessment has become a clinical domain in the new QOF. The advice on diet, exercise, smoking and issuing a scrip for simvastatin 40mg are recommended for all those with a risk greater than 20 per cent.

The WHO has published a tool for calculating 10-year risk of sustaining an osteoporotic fracture (FRAX).

We also have the QDScore that can estimate 10-year risk of type-2 diabetes.

Assessing 10-year AF risk is on its way soon, or is it already here? I cannot remember.

All we need now is a 10-year risk score for developing asthma and COPD.

The more I think about them, the more confused I become. I am convinced that we might be doing more harm to these patients. Patients are asking to be screened and treated.

I am dreading the day when a 10-year screening tool for dementia is discovered and patients start asking for anti-dementia medication.

Dr Anita Sharma, Oldham

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus